Literature DB >> 16714116

Synthesis and anticancer evaluation of bis(benzimidazoles), bis(benzoxazoles), and benzothiazoles.

Shu-Ting Huang1, I-Jen Hsei, Chinpiao Chen.   

Abstract

Four classes of UK-1 analogues were synthesized and their cytotoxicity testing against human A-549, BFTC-905, RD, MES-SA, and HeLa carcinoma cell lines was determined. The results revealed that UK-1 and four of these analogues (15-18) are potent against the cancer cell lines. In particular, compound 16 is more potent than UK-1 against A-549 and HeLa cell lines, and compounds 15, 17, and 18 selectively exhibit potent cytotoxic activity against the BFTV-905 cells (IC50 9.6 microM), A-549 cells (IC50 6.6 microM), and MES-SA cells (IC50 9.2 microM), respectively.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16714116     DOI: 10.1016/j.bmc.2006.05.007

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  12 in total

1.  Synthesis, metal ion binding, and biological evaluation of new anticancer 2-(2'-hydroxyphenyl)benzoxazole analogs of UK-1.

Authors:  Mireya L McKee; Sean M Kerwin
Journal:  Bioorg Med Chem       Date:  2007-11-12       Impact factor: 3.641

2.  Diversity-oriented synthesis of benzimidazole, benzoxazole, benzothiazole and quinazolin-4(3H)-one libraries via potassium persulfate-CuSO4-mediated oxidative coupling reactions of aldehydes in aqueous micelles.

Authors:  Atul Kumar; Ram Awatar Maurya; Deepti Saxena
Journal:  Mol Divers       Date:  2009-07-04       Impact factor: 2.943

3.  Design, synthesis and structural studies of meta-xylyl linked bis-benzimidazolium salts: potential anticancer agents against 'human colon cancer'.

Authors:  Rosenani A Haque; Muhammad Adnan Iqbal; Mohamed B Khadeer Ahamed; Ams Abdul Majid; Zena A Abdul Hameed
Journal:  Chem Cent J       Date:  2012-07-18       Impact factor: 4.215

4.  1-(Prop-2-en-1-yl)-3-[(trimethyl-sil-yl)meth-yl]benzimidazolium bromide monohydrate.

Authors:  Zeliha Baktır; Mehmet Akkurt; Nihat Sireci; Hasan Küçükbay
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-08-25

5.  1-Benzyl-3-[(trimethyl-sil-yl)meth-yl]benzimidazolium chloride monohydrate.

Authors:  Mehmet Akkurt; Ismail Celik; Hasan Küçükbay; Nihat Sireci; Orhan Büyükgüngör
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-06-26

6.  Synthesis, characterization, and pharmacological evaluation of novel azolo- and azinothiazinones containing 2,4-dihydroxyphenyl substituent as anticancer agents.

Authors:  Joanna Matysiak; Małgorzata Juszczak; Monika M Karpińska; Ewa Langner; Katarzyna Walczak; Marta Lemieszek; Alicja Skrzypek; Wojciech Rzeski; Andrzej Niewiadomy
Journal:  Monatsh Chem       Date:  2015-04-02       Impact factor: 1.451

7.  Direct catalytic arylation of heteroarenes with meso-bromophenyl-substituted porphyrins.

Authors:  Alexei Nikolaevich Kiselev; Olga Konstantinovna Grigorova; Alexei Dmitrievich Averin; Sergei Aleksandrovich Syrbu; Oskar Iosifovich Koifman; Irina Petrovna Beletskaya
Journal:  Beilstein J Org Chem       Date:  2017-08-03       Impact factor: 2.883

8.  Benzimidazole and Benzoxazole Zinc Chelators as Inhibitors of Metallo-β-Lactamase NDM-1.

Authors:  Abigail C Jackson; Tyler B J Pinter; Daniel C Talley; Adnan Baker-Agha; Dhruvil Patel; Paul J Smith; Katherine J Franz
Journal:  ChemMedChem       Date:  2020-11-19       Impact factor: 3.466

9.  Synthesis and evaluation of mutual azo prodrug of 5-aminosalicylic acid linked to 2-phenylbenzoxazole-2-yl-5-acetic acid in ulcerative colitis.

Authors:  Jamal A Jilani; Maha Shomaf; Karem H Alzoubi
Journal:  Drug Des Devel Ther       Date:  2013-07-31       Impact factor: 4.162

10.  Synthesis and Anti-Proliferative Effects of Mono- and Bis-Purinomimetics Targeting Kinases.

Authors:  Andrea Bistrović; Anja Harej; Petra Grbčić; Mirela Sedić; Sandra Kraljević Pavelić; Mario Cetina; Silvana Raić-Malić
Journal:  Int J Mol Sci       Date:  2017-11-01       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.